anti-CD303 monoclonal antibody (Miltenyi Biotec)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CD303 monoclonal antibody (Miltenyi Biotec)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionInterferons antagonistsC-Type lectin domain family 4 member C modulators
TargetsInterferonsC-Type lectin domain family 4 member C
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMiltenyi Biotec GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMiltenyi Biotec GmbH
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A